SmartCells is developing a modified version of insulin for diabetics.
Company (Acquired)
Phone: 978-927-4246
100 Cummings Center
Suite 419E
Beverly, 01915
Massachusetts, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Smart Cells | $8.9M | Dec 4, 2010 |
| Biodel | $80.1M | Feb 18, 2008 |
| AgaPharm | $0M | Apr 4, 2018 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Binding-site modified lectins and uses thereof | Jul 30, 2014 | Aug 29, 2017 | Patent |
| Conjugate based systems for controlled drug delivery | Jun 04, 2015 | Feb 28, 2017 | Patent |
| Crystalline insulin-conjugates | May 19, 2014 | Oct 11, 2016 | Patent |
| Conjugate based systems for controlled drug delivery | May 30, 2014 | Feb 23, 2016 | Patent |
| Exogenously triggered controlled release materials and uses thereof | May 01, 2014 | Aug 25, 2015 | Patent |
Download PDF